FDA Orphan Disease Clinical Trial Grants Aim To Reduce Financial Risk

Agency awards $22m to support 15 clinical trials and approximately $10m for six natural history studies in rare diseases. FDA Commissioner Gottlieb highlights the program as a way for the agency to help de-risk clinical development.